Depakote has been prescribed since 19831
Depakote is one of the first generation of a class of medications called antiepileptic drugs (AEDs). Depakote is used to treat complex partial seizures, simple and complex absence seizures, as well as acute manic symptoms in patients with bipolar disorder.1-3
Depakote
125 mg
Depakote
250 mg
Depakote
500 mg
Depakote ER
250 mg
Depakote ER
500 mg
Depakote Sprinkle Capsules
125 mg
Tablets and capsule shown are not actual size.
Depakote Delayed-Release Tablets, Depakote ER, and Depakote Sprinkle Capsules are used alone or with other medicines to treat:
Talk with your doctor or other healthcare professional about how you should take Depakote Delayed-Release Tablets, Depakote ER, or Depakote Sprinkle Capsules for epilepsy) and what to expect from your treatment.
Serious side effects including:
Do not take Depakote:
Common side effects include:
Depakote Delayed-Release Tablets, Depakote ER, and Depakote Sprinkle Capsules can also lower your blood platelet count. If you experience bruising while taking Depakote, please contact your doctor. If you experience red or purple spots on your skin; bruising; pain and swelling in your joints due to bleeding or bleeding from your mouth or nose while taking Depakote, please contact your doctor.
This is not a complete description of all of the risks and possible effects of Depakote. Please see the Medication Guide and Full Prescribing Information for additional information.
Depakote Delayed-Release Tablets and Depakote ER tablets should be swallowed whole and should not be crushed or chewed. Depakote Delayed-Release Tablets and Depakote ER can be taken with or without food and are available in tablet form in different dosage strengths so that your doctor can choose the strength that is right for you.
Available to patients with commercial prescription insurance coverage for Depakote who meet eligibility criteria. Copay assistance program is not available to patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law or by the patient’s health insurance provider. If at any time a patient begins receiving prescription drug coverage under any such federal, state, or government-funded healthcare program, patient will no longer be able to use the Depakote Savings Card and patient must call OPUS Health at 800.364.4767 to stop participation. Patients residing in or receiving treatment in certain states may not be eligible. Patients may not seek reimbursement for value received from the Depakote Savings Card from any third-party payers. Offer subject to change or discontinuance without notice. Restrictions, including monthly maximums, may apply. This is not health insurance. Please see full Terms and Conditions.
Pharmacist Instructions
DEPAKOTE comes in different dosage forms. DEPAKOTE® (divalproex sodium) delayed-release tablets, for oral use, and DEPAKOTE® ER (divalproex sodium) extended-release tablets, for oral use, are prescription medications used:
DEPAKOTE® Sprinkle Capsules (divalproex sodium delayed release capsules), for oral use, is a prescription medicine used alone or with other medicines to treat:
The most important information about DEPAKOTE is:
Do not stop taking DEPAKOTE without first talking to your healthcare provider. Stopping DEPAKOTE suddenly can cause serious problems.
DEPAKOTE can cause serious side effects, including:
Do not take DEPAKOTE if you:
Before taking DEPAKOTE, tell your healthcare provider if you:
Tell your healthcare provider about all the medicines you take, including prescription and non-prescription medicines, vitamins, herbal supplements.
Taking DEPAKOTE with certain other medicines, even for a short period of time, can cause side effects or affect how well they work. Do not start or stop other medicines without talking to your healthcare provider.
DEPAKOTE can cause other serious side effects, including:
Common side effects of DEPAKOTE include:
Please see the full Prescribing Information, including Medication Guide, for additional information about DEPAKOTE. Talk to your healthcare provider if you have questions.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit Abbvie.com/myAbbVieAssist to learn more.
If you have any questions about AbbVie's Depakote.com website that have not been answered, click here. This website and the information contained herein is intended for use by US residents only, is provided for informational purposes only, and is not intended to replace a discussion with a healthcare provider. All decisions regarding patient care must be made with a healthcare provider and consider the unique characteristics of each patient.
DEPAKOTE comes in different dosage forms. DEPAKOTE® (divalproex sodium) delayed-release tablets, for oral use, and DEPAKOTE® ER (divalproex sodium) extended-release tablets, for oral use, are prescription medications used:
The most important information about DEPAKOTE is:
Do not stop taking DEPAKOTE without first talking to your healthcare provider. Stopping DEPAKOTE suddenly can cause serious problems.
DEPAKOTE can cause serious side effects, including:
You are leaving the AbbVie website and connecting to a site that is not under the control of AbbVie. AbbVie is not responsible for the contents of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply the endorsement of the linked site by AbbVie. You should also be aware that the linked site may be governed by its own set of terms and conditions and privacy policy for which AbbVie has no responsibility.
Conversely, the presence of this link does not imply the linked site’s endorsement of Depakote.com or AbbVie.
Do you wish to leave this site?
You are about to enter a site that is for U.S. Healthcare Professionals only. By selecting "Yes" below, you certify that you are a Healthcare Professional and that you wish to proceed to the Healthcare Professionals Only section of this site. Products or treatments described on this site are available in the U.S. but may not be available in all other countries.
I am a licensed Healthcare Professional and wish to proceed to the Healthcare Professionals Only section of this site.
You are leaving the AbbVie website and connecting to the Track It! application on iTunes. This application is not a substitute for seizure safety. Please talk to your doctor for more information on seizure first aid. The Track It! application is not owned by or under the control of AbbVie. AbbVie is not responsible for the contents of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience, and the inclusion of any link does not imply the endorsement of the linked site by AbbVie. You should also be aware that the linked site may be governed by its own set of terms and conditions and privacy policy for which AbbVie has no responsibility.
Conversely, the presence of this link does not imply the linked site’s endorsement of Depakote.com or AbbVie.
Do you wish to leave this site?
The DEPAKOTE Savings Card is not available to individuals who are paying cash for their prescription or who are receiving prescription reimbursement under a state or federally funded insurance program.
This rebate form is not available to individuals who are paying cash for their prescription or who are receiving prescription reimbursement under a state or federally funded insurance program.